Our partners share insights on the trends shaping dealmaking in the Life Sciences sector—and what to watch in the months ahead. September 2026 · Life Sciences Featuring insights from Ryan Murr, Sebastian Fain, and Branden Berns. DEAL ACTIVITY What’s driving deal activity in the sector right now? Murr: Life Sciences deal volume is up substantially,…
San Francisco partner Ryan Murr, Washington, D.C. partner Stephen Glover and San Francisco partner Branden Berns are the authors of “Behind The ‘CVR Spin’ Method Of Unlocking Assets In M&A” [PDF] published by Law360 on March 11, 2024.
Ryan Murr, Stephen Glover and Branden Berns are the authors of “OpEd: How to Get Value for Non-Core Assets With CVR Spinoffs” published by The Deal on March 7, 2024.
